The Protein-Protein Interface Evolution Acts in a Similar Way to Antibody Affinity Maturation*

Understanding the evolutionary mechanism that acts at the interfaces of protein-protein complexes is a fundamental issue with high interest for delineating the macromolecular complexes and networks responsible for regulation and complexity in biological systems. To investigate whether the evolution of protein-protein interface acts in a similar way as antibody affinity maturation, we incorporated evolutionary information derived from antibody affinity maturation with common simulation techniques to evaluate prediction success rates of the computational method in affinity improvement in four different systems: antibody-receptor, antibody-peptide, receptor-membrane ligand, and receptor-soluble ligand. It was interesting to find that the same evolutionary information could improve the prediction success rates in all the four protein-protein complexes with an exceptional high accuracy (>57%). One of the most striking findings in our present study is that not only in the antibody-combining site but in other protein-protein interfaces almost all of the affinity-enhancing mutations are located at the germline hotspot sequences (RGYW or WA), indicating that DNA hot spot mechanisms may be widely used in the evolution of protein-protein interfaces. Our data suggest that the evolution of distinct protein-protein interfaces may use the same basic strategy under selection pressure to maintain interactions. Additionally, our data indicate that classical simulation techniques incorporating the evolutionary information derived from in vivo antibody affinity maturation can be utilized as a powerful tool to improve the binding affinity of protein-protein complex with a high accuracy.

[1]  J. Foote,et al.  Kinetic and affinity limits on antibodies produced during immune responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E L Sonnhammer,et al.  The imprint of somatic hypermutation on the repertoire of human germline V genes. , 1996, Journal of molecular biology.

[3]  B. Kuhlman,et al.  Structure-based protocol for identifying mutations that enhance protein-protein binding affinities. , 2007, Journal of molecular biology.

[4]  Herman W. T. van Vlijmen,et al.  Trends in Antibody Sequence Changes during the Somatic Hypermutation Process , 2006, The Journal of Immunology.

[5]  C. Milstein,et al.  Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. , 1998, Immunity.

[6]  C. Milstein,et al.  Mutation Drift and Repertoire Shift in the Maturation of the Immune Response , 1987, Immunological reviews.

[7]  K. Christopher Garcia,et al.  The Structure of Interleukin-2 Complexed with Its Alpha Receptor , 2005, Science.

[8]  Jianping Ding,et al.  Structural Basis for Recognition of CD20 by Therapeutic Antibody Rituximab* , 2007, Journal of Biological Chemistry.

[9]  G. Cohen,et al.  Interactions of protein antigens with antibodies. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Chothia,et al.  The atomic structure of protein-protein recognition sites. , 1999, Journal of molecular biology.

[11]  Ettore Novellino,et al.  Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites. , 2006, Journal of medicinal chemistry.

[12]  David Baker,et al.  Rational Design of Intercellular Adhesion Molecule-1 (ICAM-1) Variants for Antagonizing Integrin Lymphocyte Function-associated Antigen-1-dependent Adhesion* , 2006, Journal of Biological Chemistry.

[13]  D. Baker,et al.  Design of a Novel Globular Protein Fold with Atomic-Level Accuracy , 2003, Science.

[14]  H. Jacobs,et al.  Towards an understanding of somatic hypermutation. , 2001, Current opinion in immunology.

[15]  G. M. Griffiths,et al.  Molecular events during maturation of the immune response to oxazolone , 1985, Nature.

[16]  L. Presta,et al.  Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Smith‐Gill,et al.  X-ray snapshots of the maturation of an antibody response to a protein antigen , 2003, Nature Structural Biology.

[18]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[19]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[20]  M. Wabl,et al.  Genome-wide somatic hypermutation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Woody Sherman,et al.  Affinity enhancement of an in vivo matured therapeutic antibody using structure‐based computational design , 2006, Protein science : a publication of the Protein Society.

[22]  Gideon Schreiber,et al.  Rational design of faster associating and tighter binding protein complexes , 2000, Nature Structural Biology.

[23]  Anthony C. Bishop,et al.  Unnatural ligands for engineered proteins: new tools for chemical genetics. , 2000, Annual review of biophysics and biomolecular structure.

[24]  Toshiro Matsuda,et al.  Somatic mutation hotspots correlate with DNA polymerase η error spectrum , 2001, Nature Immunology.

[25]  B. Stoddard,et al.  Computational Thermostabilization of an Enzyme , 2005, Science.

[26]  A. Fedorov,et al.  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.

[27]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[28]  Andrew C. R. Martin,et al.  Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. , 2003, Journal of molecular biology.

[29]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[30]  D. F. Cox,et al.  Statistical Procedures for Agricultural Research. , 1984 .

[31]  Sachdev S Sidhu,et al.  Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Honjo,et al.  Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. , 2008, Gastroenterology.

[33]  G. Teng,et al.  Immunoglobulin somatic hypermutation. , 2007, Annual review of genetics.

[34]  J. Janin,et al.  Structural basis of macromolecular recognition. , 2002, Advances in protein chemistry.

[35]  B. Kuhn,et al.  Validation and use of the MM-PBSA approach for drug discovery. , 2005, Journal of medicinal chemistry.

[36]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[37]  Mitchell Ho,et al.  In Vitro Antibody Evolution Targeting Germline Hot Spots to Increase Activity of an Anti-CD22 Immunotoxin* , 2005, Journal of Biological Chemistry.